Wednesday, February 4, 2015
OncoMed Initiates Dosing in Phase 2 Clinical Trial of Demcizumab for the Treatment of Non-Small Cell Lung Cancer
… with first-line advanced-stage non-small cell lung cancer (NSCLC).
"Based on anti-tumor … plus standard-of-care in non-small cell lung cancer, we believe demcizumab has the … Non-Small Cell Lung Cancer
According to the American Cancer Society, lung cancer (both small …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment